How do neuroleptics affect cognitive dysfunctions in schizophrenia?

Nordic Journal of Psychiatry

Volumn 53, Issue 2, 1999, Pages 121-125

  Rund, Bjørn Rishovd ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Cognitive dysfunction; Neuroleptics; Neuropsychology; Schizophrenia

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; HUMAN; LEARNING; MEMORY; PSYCHOPHYSIOLOGY; SCHIZOPHRENIA;

EID: 0033060881     PISSN: 08039488     EISSN: None     Source Type: Journal    
DOI: 10.1080/080394899426819     Document Type: Article

References (38)

1. Rund BR, Borg NC. Cognitive deficits and cognitive training in schizophrenic patients: a review. Acta Psychiatr Scand. In press 1999.
2. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996;153:321-30.
3. Gråwe RW. Epidemiological and neuropsychological perspectives on schizophrenia [dissertation]. Trondheim: University of Trondheim; 1997.
4. Spohn HE, Strauss ME. Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. J Abnorm Psychol 1989;98:367-80.
5. Medalia A, Gold J, Merriam A. Effects of neuroleptics on neuropsychological tests results of schizophrenics. Arch Clin Neuropsychol 1988;3:249-71.
6. Bilder RM, Turkell E, Lipschutz-Broch L, Lieberman JA. Antipsychotic medication effects on neuropsychological functions. Psychopharm Bull 1992;28:353-66.
7. Spohn HE, Coyne L. The effect of attention information processing impairment of tardive dyskinesia and neuroleptics in chronic schizophrenics. Brain Cogn 1993;23:28-39.
8. Cleghorn JM, Kaplan RD, Szechtman B, Szechtman H, Brown GM. Neuroleptic effects on cognitive functions in schizophrenia. Schizophr Res 1990;3:211-9.
9. Rund BR, Zeiner P, Sundet K, Øie, Bryhn G. No vigilance deficit found in either young schizophrenic or ADHD subjects. Scand J Psychol 1998;39:101-7.
10. Cassens G, Inglis AH, Applebaum PS, Gutheil TG. Neuroleptics. Effects on neuropsychological functioning in chronic schizophrenic patients. Schizophr Bull 1990;16:477-99.
11. King DJ. The effect of neuroleptics on cognitive and psychomotor function. Br J Psychol 1990;157:799-811.
12. Corrigan PW, Penn DL. The effects of anti-psychotic and anti-parkinsonian medication on psychosocial skill learning. Clin Psychol Sci Pract 1995;2:251-62.
13. Verdoux H, Magnin E, Bourgeous M. Neuroleptic effects on neuropsychological test performance in schizophrenia. Schizophr Res 1995;14:113-39.
14. Judson AJ, MacCasland BV. The effects of chloropromazine on psychological test scores. J Consult Psychol 1960;24:192.
15. Mason-Browne ML, Bortwick JW. The effects of perphenazine (Trilafon) on modification of crude consciousness. Dis Nerv Syst 1957;18:300-6.
16. Gruzelier JH. Hammond NV. The effect of chlorpromazine upon psychophysiological endocrine and information processing measures in schizophrenia. J Psychiatr Res 1978;14:167-82.
17. Spohn HE, Coyne L, Spray J. The effect of neuroleptics on tardive dyskinesia on smooth-pursuit eye movement in chronic schizophrenics. Arch Gen Psychiatry 1988;45:833-40.
18. Strauss ME, Reynolds KS, Jayaram G, Thune LE. Effects of anticholinergic medication on memory in schizophrenia. Schizophr Res 1990;3:127-9.
19. Storzbach DM, Corrigan PW. Cognitive rehabilitation for schizophrenia. In: Corrigan PW, Yudofsky SC, editors. Cognitive rehabilitation for neuropsychiatric disorders. Washington (DC): American Psychiatric Press; 1996.
20. Green MF, Marshall BD Jr, Wirshing WC, Ames D, Marder S, McGurk S, et al. Does risperidone improve verbal working memory in treatment-resistant schizophrenia? Am J Psychiatry 1997;154:799-804.
21. Classen W, Laux G. Sensory motor and cognitive performance of schizophrenic in-patients treated with haloperidol, flupenthixol, or clozapine. Pharmacopsychiatry 1988;21:295-7.
22. Goldberg TE, Greenberg RD, Griffin SJ, Gold JM, Kleinmann JE, Pickar D, et al. The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Br J Psychiatry 1993;162:43-8.
23. Hoff AL, Faustman WO, Wieneke M, Espinoza S, Costa M, Wolkowitz O, et al. The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment refractory state hospital schizophrenic inpatients. Neuropsychopharmacology 1996;15:361-9.
24. Zahn TP, Pickard D, Haier RJ. Effects of clozapine, fluphenazine, and placebo on reaction time measures of attention and sensory dominance in schizophrenia. Schizophr Res 1994;13:133-44.
25. Lee, MA, Thompson PA, Meltzer HY. Effects of clozapine on cognitive functions in schizophrenia. J Clin Psychiatry 1994;55 Suppl B:82-7.
26. Hagger C, Buckley P, Kenny JT, Fridinan L, Ubogy D, Meltzer HY. Improvement in cognitive functions and psychiatric symptoms in treatmentrefractory schizophrenic patients receiving clozapine. Biol Psychiatry 1993;34:702-12.
27. Green MF. Schizophrenia from a neurocognitive perspective. Probing the impenetrable darkness. Boston: Allyn and Bacon; 1998.
28. Richelson E. Preclinical pharmacology of neuroleptics: focus on new generation compounds. J Clin Psychiatry 1996;57 Suppl 11:4-11.
29. Gallhofer B, Bauer U, Gruppe H, Krieger S, Lies S. First episode schizophrenia. The importance of compliance and preserving cognitive functions. J Pract Psychiatr Behav Health 1996; Suppl 2;16-24.
30. Stip E, Lussier I. The effect of risperidone on cognition in patients with schizophrenia. Can J Psychiatry 1996;41 Suppl 2:35-40.
31. Oltmanns TF, Neale JM. Schizophrenic performance when distractors are present. Attention deficit or differential task difficulty? J Abnorm Psychol 1975;84:205-9.
32. Rund BR. The effect of distraction on focal attention in paranoid and non-paranoid schizophrenic patients compared to normals and non-psychotic psychiatric patients. J Psychiatr Res 1983;17:241-50.
33. Rund BR. Distractibility and recall capability in schizophrenics. A 4 year longitudinal study of stability in cognitive performance. Schizophr Res 1989;2:265-75.
34. Kern RS, Green MF Marshall BD Jr, Wirsching WC, Wirsching D, McGurk S, et al. Risperidone vs. Haloperidol on reaction time, manual dexterity, and motor learning in treatment-resistant schizophrenia patients. Biol Psychiatry 1998;44:726-32.
35. Mockler DM, Gill S, Soni W, Morris RG, Sharma T. The effects of risperidone on attention & motor function, verbal fluency & executive function, and memory function in schizophrenia [abstract]. Schizophr Res 1998;29:146-7.
36. Burke JG, Patel JKM, Morris PK, Reveley MA. Risperidone improves antisaccade error rates in schizophrenia [abstract]. Schizophr Res 1998;29:115.
37. Taylor N, Beuzen JN, Wesnes K, Wood A. The effect of olanzapine on cognition and psychomotor function in healthy elderly volunteers [abstract]. Schizophr Res 1996;18:131.
38. Canadian Cognition and Outcome Study Group. Neuropsychological change in early phase schizophrenia over twelve months of treatment with olanzapine, risperidone, or haloperidol [abstract]. Schizophr Res 1998;29:152.